Clinical Trials Directory

Trials / Completed

CompletedNCT03466697

Role of Dopamine Transporter in Glucose Control

Role of Dopamine Transporter in Glucose Loading of Healthy Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Pusan National University Hospital · Academic / Other
Sex
All
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Healthy subjects will be enrolled in this study. Each subject will be scanned twice with F18-FP-CIT PET which is commercially available. F18-FP-CIT reflects dopamine transporter availability of striatum. Before each PET scan, subject will be injected either glucose or normal saline. Therefore, PET scan will reflect the changes of dopamine transporter availability after the injection of glucose.

Conditions

Interventions

TypeNameDescription
OTHERGlucose injection/Normal saline injectionBefore each PET scan, subject will be injected either glucose or normal saline.

Timeline

Start date
2018-03-14
Primary completion
2021-12-20
Completion
2021-12-20
First posted
2018-03-15
Last updated
2022-04-20

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03466697. Inclusion in this directory is not an endorsement.

Role of Dopamine Transporter in Glucose Control (NCT03466697) · Clinical Trials Directory